CarolynKMcCourtMD
Obstetrics & Gynecology • Saint Louis, MOGynecologic Oncology
Assistant Professor, Obstetrics and Gynecology, Brown University Program in Medicine
Dr. McCourt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-362-3181Fax+1 314-362-2893
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Obstetrics and Gynecology, 2001 - 2005
Creighton University School of MedicineClass of 2001
Certifications & Licensure
IL State Medical License 2020 - 2026
MO State Medical License 2014 - 2025
RI State Medical License 2005 - 2016
CT State Medical License 2008 - 2014
MA State Medical License 2008 - 2014- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
- Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer Start of enrollment: 2010 Sep 07
- Panitumumab and Gemcitabine in Relapsed Ovarian Cancer Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 29 citationsComprehensive care in gynecologic oncology: The importance of palliative careLisa M. Landrum, Stephanie V. Blank, Lee-may Chen, Linda R. Duska, Victoria L. Bae-Jump
Gynecologic Oncology. 2015-05-01 - 127 citationsA phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: A gynecologic oncol...David H. Moore, Shamshad Ali, Wui Jin Koh, Helen Michael, Mack N. Barnes
Gynecologic Oncology. 2011-03-01 - 49 citationsEffect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial.Kevin Kalinsky, Fangxin Hong, Carolyn K. McCourt, Jasgit C. Sachdev, Edith P. Mitchell
JAMA Oncology. 2021-02-01
Journal Articles
- Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian CancerIan S Hagemann, Premal H Thaker, Carolyn K McCourt, Katherine C Fuh, David G Mutch, Andrea R Hagemann, Matthew A Powell, Clinical Cancer Research
- Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous CancerIan S Hagemann, Carolyn K McCourt, Matthew A Powell, Premal H Thaker, David G Mutch, Katherine C Fuh, Andrea R Hagemann, Clinical Cancer Research
Press Mentions
NCI-MATCH Cancer Trial Finds a Promising Signal for the AKT Inhibitor IpatasertibOctober 26th, 2022
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
